Abstract
Fluorescein angiography (FA) is a standard imaging modality for evaluating vascular abnormalities in retina-related diseases, which is recognized as the major cause of vision loss. Long-term and real-time fundus angiography is of great importance in preclinical research, nevertheless remaining big challenges up to present. In this study, we demonstrate that long-term fluorescence imaging of retinal vessels is enabled through a kind of fluorescent nanoagents, which is made of small-sized (hydrodynamic diameter: ∼ 3 nm) silicon nanoparticles (SiNPs) featuring strong fluorescence, robust photostability, lengthened blood residency and negligible toxicity. In particular, the presented SiNPs-based nanoagents are capable of imaging retinal capillaries in ∼ 10 min, which is around 10-fold longer than that (∼ 1 min) of fluorescein sodium (FS, known as the most widely used contrast agents for FA in clinic). Taking cynomolgus macaques as non-human primate-animal model, we further demonstrate the feasibility of real-time diagnosis of retinal diseases (e.g., age-related macular degeneration (AMD)) through dynamic monitoring of vascular dysfunction.
Similar content being viewed by others
References
Zhang, K.; Zhang, L. F.; Weinreb, R. N. Ophthalmic drug discovery: Novel targets and mechanisms for retinal diseases and glaucoma. Nat. Rev. Drug. Discov. 2012, 11, 541–559.
Kim, D. Y.; Fingler, J.; Zawadzki, R. J.; Park, S. S.; Morse, L. S.; Schwartz, D. M.; Fraser, S. E.; Werner, J. S. Optical imaging of the chorioretinal vasculature in the living human eye. Proc. Natl. Acad. Sci. USA 2013, 110, 14354–14359.
Stanga, P. E.; Lim, J. I.; Hamilton, P. Indocyanine green angiography in chorioretinal diseases: Indications and interpretation: An evidence-based update. Ophthalmology 2003, 110, 15–21.
Antonelli, A.; Sfara, C.; Magnani, M. Intravascular contrast agents in diagnostic applications: Use of red blood cells to improve the lifespan and efficacy of blood pool contrast agents. Nano Res. 2017, 10, 731–766.
Pearlman, J. D.; Laham, R. J.; Post, M.; Leiner, T.; Simons, M. Medical imaging techniques in the evaluation of strategies for therapeutic angiogenesis. Curr. Pharm. Des. 2002, 8, 1467–1496.
Huang, J. G.; Li, J. C.; Lyu, Y.; Miao, Q. Q.; Pu, K. Y. Molecular optical imaging probes for early diagnosis of drug-induced acute kidney injury. Nat. Mater. 2019, 18, 1133–1143.
Miao, Q. Q.; Xie, C.; Zhen, X.; Lyu, Y.; Duan, H. W.; Liu, X. G.; Jokerst, J. V.; Pu, K. Y. Molecular afterglow imaging with bright, biodegradable polymer nanoparticles. Nat. Biotechnol. 2017, 35, 1102–1110.
Cursiefen, C.; Chen, L.; Saint-Geniez, M.; Hamrah, P.; Jin, Y. P.; Rashid, S.; Pytowski, B.; Persaud, K.; Wu, Y.; Streilein, J. W. et al. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc. Natl. Acad. Sci. USA 2006, 103, 11405–11410.
Fan, Y.; Wang, P. Y.; Lu, Y. Q.; Wang, R.; Zhou, L.; Zheng, X. L.; Li, X. M.; Piper, J. A.; Zhang, F. Lifetime-engineered NIR-II nanoparticles unlock multiplexed in vivo imaging. Nat. Nanotechnol. 2018, 13, 941–946.
Takahashi, K.; Muraoka, K.; Kishi, S.; Shimizu, K. Formation of retinochoroidal collaterals in central retinal vein occlusion. Am. J. Ophthalmol. 1998, 126, 91–99.
Wolfensberger, T. J.; Herbort, C. P. Indocyanine green angiographic features in ocular sarcoidosis. Ophthalmology 1999, 106, 285–289.
Aydin, P.; Akova, Y. A.; Kadayifçilar, S. Anterior segment indocyanine green angiography in scleral inflammation. Eye 2000, 14, 211–215.
Nicholson, B.; Noble, J.; Forooghian, F.; Meyerle, C. Central serous chorioretinopathy: Update on pathophysiology and treatment. Surv. Ophthalmol. 2013, 58, 103–126.
Shinojima, A.; Kawamura, A.; Mori, R.; Yuzawa, M. Morphologic features of focal choroidal excavation on spectral domain optical coherence tomography with simultaneous angiography. Retina 2014, 34, 1407–1414.
Yannuzzi, L. A. A perspective on the treatment of aphakic cystoid macular edema. Surv. Ophthalmol. 1984, 28, 540–553.
Fardeau, C.; Lee, C. P. L.; Merle-Béral, H.; Cassoux, N.; Bodaghi, B.; Davi, F.; Lehoang, P. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-hodgkin primary intraocular lymphoma. Am. J. Ophthalmol. 2009, 147, 886–894.
Antcliff, R. J.; Stanford, M. R.; Chauhan, D. S.; Graham, E. M.; Spalton, D. J.; Shilling, J. S.; Ffytche, T. J.; Marshall, J. Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology 2000, 107, 593–599.
Spaide, R. F.; Yannuzzi, L. A.; Sisco, L. J. Chronic cystoid macular edema and predictors of visual acuity. Ophthalmic Surg. 1993, 24, 262–267.
Jia, Y. L.; Bailey, S. T.; Hwang, T. S.; McClintic, S. M.; Gao, S. S.; Pennesi, M. E.; Flaxel, C. J.; Lauer, A. K.; Wilson, D. J.; Hornegger, J. et al. Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. Proc. Natl. Acad. Sci. USA 2015, 112, 2395–2402.
Weng, Y. H.; Ma, X. W.; Che, J.; Li, C.; Liu, J.; Chen, S. Z.; Wang, Y. Q.; Gan, Y. L.; Chen, H.; Hu, Z. B. et al. Nanomicelle-assisted targeted ocular delivery with enhanced antiinflammatory efficacy in vivo. Adv. Sci. 2018, 5, 1700455.
Wang, Y. F.; Liu, C. H.; Ji, T. J.; Mehta, M.; Wang, W. P.; Marino, E.; Chen, J.; Kohane, D. S. Intravenous treatment of choroidal neovascularization by photo-targeted nanoparticles. Nat. Commun. 2019, 10, 804.
Shen, J. K.; Kim, J.; Tzeng, S. Y.; Ding, K.; Hafiz, Z.; Long, D.; Wang, J. X.; Green, J. J.; Campochiaro, P. A. Suprachoroidal gene transfer with nonviral nanoparticles. Sci. Adv. 2020, 6, eaba1606.
Zhou, J.; Liu, Q.; Feng, W.; Sun, Y.; Li, F. Y. Upconversion luminescent materials: Advances and applications. Chem. Rev. 2015, 115, 395–465.
Yao, J.; Yang, M.; Duan, Y. X. Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: New insights into biosensing, bioimaging, genomics, diagnostics, and therapy. Chem. Rev. 2014, 114, 6130–6178.
Kwon, J.; Jun, S. W.; Choi, S. I.; Mao, X.; Kim, J.; Koh, E. K.; Kim, Y. H.; Kim, S. K.; Hwang, D. Y.; Kim, C. S. et al. FeSe quantum dots for in vivo multiphoton biomedical imaging. Sci. Adv. 2019, 5, eaay0044.
Wang, R.; Li, X. M.; Zhou, L.; Zhang, F. Epitaxial seeded growth of rare-earth nanocrystals with efficient 800 nm near-infrared to 1525 nm short-wavelength infrared downconversion photoluminescence for in vivo bioimaging. Angew. Chem., Int. Ed. 2014, 53, 12086–12090.
Zhou, L.; Wang, R.; Yao, C.; Li, X. M.; Wang, C. L.; Zhang, X. Y.; Xu, C. J.; Zeng, A. J.; Zhao, D. Y.; Zhang, F. Single-band upconversion nanoprobes for multiplexed simultaneous in situ molecular mapping of cancer biomarkers. Nat. Commun. 2015, 6, 6938.
Su, Y. Y.; Ji, X. Y.; He, Y. Water-dispersible fluorescent silicon nanoparticles and their optical applications. Adv. Mater. 2016, 28, 10567–10574.
Peng, F.; Su, Y. Y.; Zhong, Y. L.; Fan, C. H.; Lee, S. T.; He, Y. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy. Acc. Chem. Res. 2014, 47, 612–623.
Zhong, Y. L.; Song, B.; Shen, X. B.; Guo, D. X.; He, Y. Fluorescein sodium ligand-modified silicon nanoparticles produce ultrahigh fluorescence with robust pH- and photo-stability. Chem. Commun. 2019, 55, 365–368.
Cui, M. Y.; Liu, S. M.; Song, B.; Guo, D. X.; Wang, J. H.; Hu, G. Y.; Su, Y. Y.; He, Y. Fluorescent silicon nanorods-based nanotheranostic agents for multimodal imaging-guided photothermal therapy. Nano-Micro Lett. 2019, 11, 73.
Wang, J. H.; Song, B.; Tang, J. L.; Hu, G. Y.; Wang, J. Y.; Cui, M. Y.; He, Y. Multi-modal anti-counterfeiting and encryption enabled through silicon-based materials featuring pH-responsive fluorescence and room-temperature phosphorescence. Nano Res. 2020, 13, 1614–1619.
Guo, D. X.; Ji, X. Y.; Peng, F.; Zhong, Y. L.; Chu, B. B.; Su, Y. Y.; He, Y. Photostable and biocompatible fluorescent silicon nanoparticles for imaging-guided co-delivery of siRNA and doxorubicin to drug-resistant cancer cells. Nano-Micro Lett. 2019, 11, 27.
Ji, X. Y.; Guo, D. X.; Song, B.; Wu, S. C.; Chu, B. B.; Su, Y. Y.; He, Y. Traditional Chinese medicine molecule-assisted chemical synthesis of fluorescent anti-cancer silicon nanoparticles. Nano Res. 2018, 11, 5629–5641.
Zhai, X.; Song, B.; Chu, B. B.; Su, Y. Y.; Wang, H. Y.; He, Y. Highly fluorescent, photostable, and biocompatible silicon theranostic nanoprobes against Staphylococcus aureus infections. Nano Res. 2018, 11, 6417–6427.
Tang, M. M.; Ji, X. Y.; Xu, H.; Zhang, L.; Jiang, A. R.; Song, B.; Su, Y. Y.; He, Y. Photostable and biocompatible fluorescent silicon nanoparticles-based theranostic probes for simultaneous imaging and treatment of ocular neovascularization. Anal. Chem. 2018, 90, 8188–8195.
Zhang, L.; Ji, X. Y.; Su, Y. Y.; Zhai, X.; Xu, H.; Song, B.; Jiang, A. R.; Guo, D. X.; He, Y. Fluorescent silicon nanoparticles-based nanotheranostic agents for rapid diagnosis and treatment of bacteria-induced keratitis. Nano Res. 2020, 14, 52–58.
Lambert, V.; Lecomte, J.; Hansen, S.; Blacher, S.; Gonzalez, M. L. A.; Struman, I.; Sounni, N. E.; Rozet, E.; de Tullio, P.; Foidart, J. M. et al. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat. Protoc. 2013, 5, 2197–2211.
Liu, Z.; Fan, A. C.; Rakhra, K.; Sherlock, S.; Goodwin, A.; Chen, X. Y.; Yang, Q. W.; Felsher, D. W.; Dai, H. J. Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy. Angew. Chem., Int. Ed. 2009, 45, 7668–7672.
Laginha, K. M.; Verwoert, S.; Charrois, G. J. R.; Allen, T. M. Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clin. Cancer. Res. 2005, 11, 6944–6949.
Nakayama-Ratchford, N.; Bangsaruntip, S.; Sun, X. M.; Welsher, K.; Dai, H. J. Noncovalent functionalization of carbon nanotubes by fluorescein-polyethylene glycol: Supramolecular conjugates with pH-dependent absorbance and fluorescence. J. Am. Chem. Soc. 2007, 129, 2448–2449.
Park, J.; Hammond, P. T. Multilayer transfer printing for polyelectrolyte multilayer patterning: Direct transfer of layer-by-layer assembled micropatterned thin films. Adv. Mater. 2004, 16, 520–525.
Luo, L.; Zhang, X. H.; Hirano, Y.; Tyagi, P.; Barabas, P.; Uehara, H.; Miya, T. R.; Singh, N.; Archer, B.; Qazi, Y. et al. Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration. ACS Nano 2013, 7, 3264–3275.
Haarhaus, M.; Brandenburg, V.; Kalantar-Zadeh, K.; Stenvinkel, P.; Magnusson, P. Alkaline phosphatase: A novel treatment target for cardiovascular disease in CKD. Nat. Rev. Nephrol. 2017, 13, 429–442.
Hauck, T. S.; Anderson, R. E.; Fischer, H. C.; Newbigging, S.; Chan, W. C. W. In vivo quantum-dot toxicity assessment. Small 2010, 6, 138–144.
Yong, K. T.; Law, W. C.; Hu, R.; Ye, L.; Liu, L. W.; Swihart, M. T.; Prasad, P. N. Nanotoxicity assessment of quantum dots: From cellular to primate studies. Chem. Soc. Rev. 2013, 42, 1236–1250.
Ghosh, J. G.; Nguyen, A. A.; Bigelow, C. E.; Poor, S.; Qiu, Y. B.; Rangaswamy, N.; Ornberg, R.; Jackson, B.; Mak, H.; Ezell, T. et al. Long-acting protein drugs for the treatment of ocular diseases. Nat. Commun. 2017, 8, 14837.
Kulkarni, A. D.; Kuppermann, B. D. Wet age-related macular degeneration. Adv. Drug. Deliv. Rev. 2005, 57, 1994–2009.
Goody, R. J.; Hu, W. Z.; Shafiee, A.; Struharik, M.; Bartels, S.; López, F. J.; Lawrence, M. S. Optimization of laser-induced choroidal neovascularization in African green monkeys. Exp. Eye Res. 2011, 92, 464–472.
Sidman, R. L.; Li, J. X.; Lawrence, M.; Hu, W. Z.; Musso, G. F.; Giordano, R. J.; Cardó-Vila, M.; Pasqualini, R.; Arap, W. The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. Sci. Transl. Med. 2015, 7, 309ra165.
Ye, L.; Yong, K. T.; Liu, L. W.; Roy, I.; Hu, R.; Zhu, J.; Cai, H. X.; Law, W. C.; Liu, J. W.; Wang, K. et al. A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots. Nat. Nanotechnol. 2012, 7, 453–458.
Chen, F.; Madajewski, B.; Ma, K.; Zanoni, D. K.; Stambuk, H.; Turker, M. Z.; Monette, S.; Zhang, L.; Yoo, B.; Chen, P. M. et al. Molecular phenotyping and image-guided surgical treatment of melanoma using spectrally distinct ultrasmall core-shell silica nanoparticles. Sci. Adv. 2019, 5, eaax5208.
Munson, M. C.; Plewman, D. L.; Baumer, K. M.; Henning, R.; Zahler, C. T.; Kietzman, A. T.; Beard, A. A.; Mukai, S.; Diller, L.; Hamerly, G. et al. Autonomous early detection of eye disease in childhood photographs. Sci. Adv. 2019, 5, eaax6363.
Acknowledgements
We appreciate financial support from National Natural Science Foundation of China (Nos. 21825402, 31400860, 21575096, and 21605109), Natural Science Foundation of Jiangsu Province of China (Nos. BK20191417 and BK20170061) and the Program for Jiangsu Specially-Appointed Professors to Prof. Yao He, a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
12274_2021_3302_MOESM1_ESM.pdf
Long-term fundus fluorescence angiography and real-time diagnosis of retinal diseases in non-human primate-animal models
Rights and permissions
About this article
Cite this article
Tang, M., Zhang, L., Song, B. et al. Long-term fundus fluorescence angiography and real-time diagnosis of retinal diseases in non-human primate-animal models. Nano Res. 14, 3840–3847 (2021). https://doi.org/10.1007/s12274-021-3302-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12274-021-3302-6